EPG Online Twitter
EPG Online Blog
Disease Knowledge
Drug Updates
- Fostair 100/6 inhalation solution
- Epanutin capsules 25, 50 and 100mg
- Eprex 2000, 4000 and 10000 IU/ml solution for injection in pre-filled syringe
- FemSeven Conti
- Epanutin 300mg hard capsules
- Bedranol 80mg SR Capsules
- Bedranol 160mg SR Capsules
- Betim 10mg Tablets
- Carbo-Dome Cream
- Bisoprolol 2.5mg/5mg/10mg film coated tablet
- Phenergan Injection
- Rivotril 0.5 mg and 2 mgTablets
- Rivotril Ampoules
- RELPAX 20mg and 40mg Film-Coated Tablets
- Witch Doctor ® 81.5%w/w Gel
- Levetiracetam Actavis 1,000 mg film-coated tablets
- Levetiracetam Actavis 250 mg film-coated tablets
- Levetiracetam Actavis 500 mg film-coated tablets
- Levetiracetam Actavis 750 mg film-coated tablets
- Lidocaine Hydrochloride Injection BP 1% w/v plastic ampoules
- Lidocaine Hydrochloride Injection BP 2.0% w/v
- Omeprazole 10mg Capsules
- Omeprazole 20mg Capsules
- Panadol Extra Advance 500 mg/65 mg Tablets
- Allopurinol Tablets BP 300mg
- Allopurinol Tablets BP 100mg
- Anadin Ultra Double Strength 400mg Capsules/Anadin LiquiFast 400mg Capsules
- Calcipotriol Scalp Solution
- Bupivacaine Hydrochloride Injection BP 0.5% w/v.
- Lescol (fluvastatin* sodium) 20 mg and 40 mg capsules
- Meropenem 1 g Powder for Solution for Injection or Infusion
- VALTREX Tablets 250mg
- Vesicare 5mg & 10mg film-coated tablets
- Zomig 5mg Nasal Spray
- Water for Injections
- Tizanidine 2mg Tablets
- NovoRapid 100 U/ml in a vial, NovoRapid Penfill 100 U/ml, NovoRapid FlexPen 100 U/ml, NovoRapid FlexTouch 100 U/ml
- Orfadin 10 mg hard capsules
- Orfadin 2 mg hard capsules
- Natecal D3 Chewable Tablets
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
Low molecular weight heparins (LMWHs, anticoagulants).
Certoparin
Solution in pre-filled syringes.
Injection, certoparin 3000 i.u. anti-Factor Xa activity.
Prophylaxis of peri- and post- operative venous thromboembolism.
3000 i.u. daily by subcutaneous injection into the peritoneal fold 1 - 2 hours prior to surgery. Repeat once daily for 7 to 10 days or until mobile.
Not recommended.
Major bleeding disorders, bleeding ulcers of the stomach or intestine, severe hypertension (>200/120mmHg), hypersensitivity to heparin, subacute bacterial endocarditis, severe renal and/or hepatic dysfunction.
Must not be administered intramuscularly. Monitor platelet counts. May cause hyperkalaemia, particularly in diabetes mellitus, chronic renal failure, mellitus, chronic renal failure, pre-existing metabolic acidosis, patients with raised plasma potassium or taking potassium- sparing drugs; measure plasma potassium before starting therapy, and monitor regularly thereafter, especially if treatment prolonged beyond 7 days. Spinal or epidural anaesthesia - risk of spinal haematomas and paralysis; observe patients carefully. Pregnancy and lactation.
NSAIDs, oral anticoagulants, dipyridamole, dextrans, etacrynic acid (ethacrynic acid), cytostatic agents, antihistamines, digitalis, tetracyclines, ascorbic acid.
Minor bleeding at injection site, thrombocytopenia, hypersensitivity reactions, raised liver enzymes, osteoporosis. Rarely, clinically significant hyperkalaemia. Very rarely, spinal haematomas in patients undergoing spinal or epidural anaesthesia.
Grifols
(POM)
04 June 2009
- ACTILYSE
- AGGRASTAT
- ALPHAPARIN
- ANGETTES 75
- ASASANTIN RETARD
- Aspirin (MI)
- CANUSAL
- CAPRIN (MI)
- CLIVARINE
- Clopidogrel 75 mg Film-coated Tablets
- Dipyridamole
- DISPRIN CV
- FLOLAN
- Fragmin - Treatment of VTE
- Heparin calcium 25,000 I.U./ml Solution for injection or concentrate for solution for infusion
- HEPSAL
- INTEGRILIN
- KABIKINASE





